You have to answer a biomedical question in binary format, i.e. only yes and no are the only acceptable answer formats. A list of paragraphs is provided as context to help you answer the question.

Question: Is neurofilament light marker for disease?

Context: sNfL levels during the first demyelinating event of MS are associated with greater impairment of BBB integrity, immune cell extravasation, and brain lesion activity on MRI.
Neurofilament light chain (NfL) has recently been proposed as a promising biomarker in frontotemporal dementia (FTD). We investigated the correlation of both cerebrospinal fluid (CSF) and serum NfL with detailed neuropsychological data and cognitive decline in a cohort of sporadic and familial FTD.
Neurofilament light chain has a potential role in differentiating patients with frontotemporal dementia from healthy controls, patients with Alzheimer's dementia, and psychiatric disorders.
Serum neurofilament light chain (sNfL) is a marker of neuroaxonal injury.
sNfL is associated with ongoing neuroinflammation and predictive of future neurodegeneration in early MS.
Neurofilament light chain (NfL) is a relatively new biomarker for MS diagnosis and follow up.
yes